| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |